| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9719 |
| Human Intestinal Absorption | HIA+ | 0.9896 |
| Caco-2 Permeability | Caco2+ | 0.8776 |
| P-glycoprotein Substrate | Non-substrate | 0.8592 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9931 |
| Non-inhibitor | 0.9959 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9134 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8206 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8068 |
| CYP450 2D6 Substrate | Non-substrate | 0.9432 |
| CYP450 3A4 Substrate | Non-substrate | 0.7680 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5302 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8216 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9250 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8698 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9480 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9819 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9600 |
| Non-inhibitor | 0.9814 |
| AMES Toxicity | Non AMES toxic | 0.9777 |
| Carcinogens | Non-carcinogens | 0.5509 |
| Fish Toxicity | High FHMT | 0.9024 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9860 |
| Honey Bee Toxicity | High HBT | 0.7233 |
| Biodegradation | Not ready biodegradable | 0.6629 |
| Acute Oral Toxicity | III | 0.9567 |
| Carcinogenicity (Three-class) | Non-required | 0.6993 |